A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE EFFECTS OF VITAMIN B12, B6 AND FOLIC ACID ON COGNITION AND SYMPTOMS IN FIRST-EPISODE PSYCHOSIS: THE VITAMINS IN PSYCHOSIS STUDY

被引：1
|
作者：
Allott, Kelly [1 ]
McGorry, Patrick [1 ]
Yuen, Hok Pan [1 ]
O'Donnell, Colin [2 ]
机构：
[1] Orygen, Parkville, Vic, Australia
[2] Donegal Mental Hlth Serv, Dublin, Ireland
来源：
SCHIZOPHRENIA BULLETIN | 2018年 / 44卷
关键词：
D O I：
10.1093/schbul/sby016.320
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
T44
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [41] Comparison of first-episode psychosis and first- episode mania patients with healthy controls regarding serum vitamin B12 and folate levels
    Kapici, Yasar
    Almis, Behice Han
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2022, 35 (03): : 147 - 154
  • [42] Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)
    Tengelmann, Caroline
    Joos, Stefanie
    Kaussner, Yvonne
    Malzahn, Uwe
    Lunden, Laura
    Klug, Andreas
    Hausler, Karl Georg
    Escales, Catharina
    Maetzler, Walter
    Hugen, Klemens
    Zolk, Oliver
    Heuschmann, Peter U.
    Forster, Christian
    Kaduszkiewicz, Hanna
    Gagyor, Ildiko
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [43] Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)
    Caroline Tengelmann
    Stefanie Joos
    Yvonne Kaußner
    Uwe Malzahn
    Laura Lunden
    Andreas Klug
    Karl Georg Häusler
    Catharina Escales
    Walter Maetzler
    Klemens Hügen
    Oliver Zolk
    Peter U. Heuschmann
    Christian Förster
    Hanna Kaduszkiewicz
    Ildikó Gágyor
    BMC Infectious Diseases, 24
  • [44] Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women
    Christen, William G.
    Glynn, Robert J.
    Chew, Emily Y.
    Albert, Christine M.
    Manson, JoAnn E.
    OPHTHALMIC EPIDEMIOLOGY, 2016, 23 (01) : 32 - 39
  • [45] Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis
    Foley, Eimear M.
    Griffiths, Sian Lowri
    Murray, Alexander
    Rogers, Jack
    Corsi-Zuelli, Fabiana
    Hickinbotham, Hannah
    Warwick, Ella
    Wilson, Martin
    Kaser, Muzaffer
    Murray, Graham K.
    Deakin, Bill
    Jadon, Deepak
    Suckling, John
    Barnes, Nicholas M.
    Upthegrove, Rachel
    Khandaker, Golam M.
    BMJ OPEN, 2023, 13 (03):
  • [46] Treatment of acute neuroleptic-induced akathisia with vitamin B6: Double blind, placebo-controlled study
    Lerner, V
    Bergman, J
    Statsenko, N
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S281 - S281
  • [47] Efficacy of vitamins B1 and B6 as an adjunctive therapy to lithium in bipolar-I disorder: A double-blind, randomized, placebo-controlled, clinical trial
    Zandifar, Atefeh
    Mousavi, Shaghayegh
    Schmidt, Norman Brad
    Badrfam, Rahim
    Seif, Ehsan
    Qorbani, Mostafa
    Natanzi, Mahboobeh Mehrabani
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 345 : 103 - 111
  • [48] A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease
    Connelly, Peter J.
    Prentice, Neil P.
    Cousland, Gary
    Bonham, Jim
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (02) : 155 - 160
  • [49] The effect of vitamin B12 supplementation during pregnancy on infant growth and development in Nepal: a community-based, double-blind, randomised, placebo-controlled trial Reply
    Strand, Tor A.
    McCann, Adrian
    Kvestad, Ingrid
    Chandyo, Ram K.
    LANCET, 2024, 403 (10435): : 1450 - 1450
  • [50] B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
    Hankey, G. J.
    Eikelboom, J. W.
    Baker, R. I.
    Gelavis, A.
    Hickling, S. C.
    Jamrozik, K.
    van Bockxmeer, F. M.
    Vasikaran, S.
    Hankey, G. J.
    Chen, C.
    Eikelboom, J. W.
    Lees, K. R.
    Yi, Q.
    Hankey, G. J.
    Algra, A.
    Chen, C.
    Wong, M. C.
    Cheung, R.
    Wong, L.
    Divjak, I.
    Ferro, J.
    de Freitas, G.
    Gommans, J.
    Groppa, S.
    Hill, M.
    Spence, J. D.
    Lees, K. R.
    Lisheng, L.
    Navarro, J.
    Ranawaka, U.
    Ricci, S.
    Schmidt, R.
    Slivka, A.
    Tan, K.
    Tsiskaridze, A.
    Uddin, W.
    Vanhooren, G.
    Xavier, D.
    Armitage, J.
    Hobbs, M.
    Le, M.
    Sudlow, C.
    Wheatley, K.
    Yi, Q.
    Brown, W.
    Bulder, M.
    Eikelboom, J. W.
    Hankey, G. J.
    Ho, W. K.
    Jamrozik, K.
    LANCET NEUROLOGY, 2010, 9 (09): : 855 - 865
12345